Blood rheology and aging

Journal of Geriatric Cardiology

Volumn 10, Issue 3, 2013, Pages 291-301

  Simmonds, Michael J ^a   Meiselman, Herbert J ^b   Baskurt, Oguz K ^c  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KOÇ UNIVERSITY   (Turkey)

Author keywords

Aggregation; Deformability; Elderly; Erythrocyte; Red blood cell; Viscosity

Indexed keywords

FIBRINOGEN;

AGING; BLOOD CELL; BLOOD FLOW; BLOOD RHEOLOGY; BLOOD VISCOSITY; DISEASE ACTIVITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE LIFESPAN; EXERCISE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; HYDRODYNAMICS; INFLAMMATION; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PLASMA VISCOSITY; REVIEW; TISSUE PERFUSION;

EID: 84885730803     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.03.010     Document Type: Review

References (96)

1. Whittaker SRF, Winton FR. The apparent viscosity of blood flowing in the isolated hindlimb of the dog and its variation with corpuscular concentration. J Physiol Lond 1933; 78: 339-368.
2. Baskurt OK, Yalcin O, Meiselman HJ. Hemorheology and vascular control mechanisms. Clin Hemorheol Microcirc 2004; 30: 169-178.
3. Yalcin O, Uyuklu M, Armstrong JK, et al. Graded alterations of RBC aggregation influence in vivo blood flow resistance. Am J Physiol-Heart Circ Physiol 2004; 287: H2644-H2650.
4. Baskurt OK, Levi E, Caglayan S, et al. The role of hemorheological factors in the coronary circulation. Clin Hemorheol 1991; 11: 121-127.
5. Meiselman HJ. Hemorheologic alterations in hypertension: chicken or egg? Clin Hemorheol Microcirc 1999; 21: 195-200.
6. Cokelet G. Hemorheology and Hemodynamics. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2011; 3: 1-140.
7. Cokelet GR, Meiselman HJ. Macro- and micro-rheological properties of blood. In Handbook of Hemorheology and Hemodynamics; Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, Eds.; IOS Press: Amsterdam, Berlin, Oxford, Tokyo, Washington, DC, USA. 2007; pp. 45-71.
8. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003; 29: 435-450.
9. Chien S. Red cell deformability and its relevance to blood flow. Ann Rev Physiol 1987; 49: 177-192.
10. Baskurt OK, Meiselman HJ. Lessons from comparative hemorheology studies. Clin Hemorheol Microcirc 2010; 45: 101-108.
11. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood 2008; 112: 3939-3948.
12. Rampling MW, Meiselman HJ, Neu B, et al. Influence of cell-specific factors on red blood cell aggregation. Biorheology 2004; 41: 91-112.
13. Baskurt OK, Meiselman HJ. Red blood cell aggregability. Clin Hemorheol Microcirc 2009; 43: 353-354.
14. Baskurt OK, Meiselman HJ. In vivo hemorheology. In Handbook of Hemorheology and Hemodynamics; Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, Eds.; IOS Press: Amsterdam, Berlin, Oxford, Tokyo, Washington, DC, USA, 2007; pp. 322-338.
15. Baskurt OK. In vivo correlates of altered blood rheology. Biorheology 2008; 45: 629-638.
16. Baskurt OK, Meiselman HJ. Erythrocyte aggregation: basic aspects and clinical importance. Clin Hemorheol Microcirc 2012; 53: 23-37.
17. Chien S, Dormandy J, Ernst E, et al. Clinical Hemorheology, Martinus Nijhoff Publ.: Dordrecht/Boston/Lancaster, 1987.
18. Isbister JP, Hyperviscosity: Clinical disorders. In Handbook of Hemorheology and Hemodynamics; Baskurt OK, Hardeman MR, Rampling MW, et al, Eds; IOS Press: Amsterdam, the Netherlands, 2007; pp. 371-391.
19. Lowe GDO. Clinical Blood Rheology, CRC Press: Boca Raton, FL, USA, 1988.
20. Toth K, Kesmarky G. Clinical significance of hemorheological alterations. In Hand book of hemorheology and hemodynamics; Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, Eds., IOS Press: Amsterdam, Berlin, Oxford, Tokyo, Washington DC, 2007; pp. 392-432.
21. Kwaan HC, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemostas 1999; 25: 199-208.
22. Kwaan H, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost 2003; 29: 451-458.
23. Baskurt OK, Meiselman HJ. Iiatrogenic hyperviscosity and thromboss. Semin Thromb Hemost 2012; 38: 854-864.
24. Whicher JT. Cytokines and acute phase proteins. Rev Port Hemorreol 1990; 5: 49-56.
25. Kwaan HC. Role of plasma proteins in whole blood viscosity: A brief clinical review. Clin Hemorheol Microcirc 2010; 44: 167-176.
26. Rampling M. Hyperviscosity as a Complication in a Variety of Disorders. Semin Thromb Hemost 2003; 29: 459-466.
27. Alexy T, Sangkatumvong S, Connes P, et al. Sickle cell disease: Selected aspects of pathophysiology. Clin Hemorheol Microcirc 2010; 44: 155-166.
28. Beutler E. Hemoglobinopathies associated with unstable hemoglobin. In Williams Hematology; Beutler E, Lichtman MA, Coller BS, Eds.; McGraw Hill, 2001; pp. 607-610.
29. Baskurt OK. Mechanisms of blood rheology alterations. In Handbook of Hemorheology and Hemodynamics; Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, Eds.; IOS Press: Amsterdam, Berlin, Oxford, Tokyo, Washington, DC, USA, 2007; pp. 170-190.
30. An XU, Mohandas N. Disorders of red cell membrane. Br J Haematol 2008; 141: 367-375.
31. George A, Pushkaran S, Li LN, et al. Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: The role of protein kinase C, Rac GTPases, and reactive oxygen species. Blood Cells Mol Dis 2010; 45: 41-45.
32. Muravyov AV, Tikhomirova IA. Role of molecular signaling pathways in changes of red blood cell deformability. Clin Hemorheol Microcirc 2013; 53: 45-59.
33. Rampling MW. Red cell aggregation and yield stress. In Clinical Blood Rheology; Lowe GDO, Ed., CRC Press, Inc.: Florida, 1988; pp. 45-64.
34. Raphael SS. Lynch's Medical Laboratory Technology, W.B. Saunders Co.: Philadelphia, 1983.
35. Berliner S, Rogowski O, Aharonov S, et al. Erythrocyte adhesiveness/ aggregation; A novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J 2005; 149: 260-267.
36. Baskurt OK, Neu B, Meiselman HJ. Red blood cell aggregation, CRC Press: Boca Raton, Florida, 2012.
37. Baskurt OK, Meiselman HJ. Erythrocyte aggregation: basic aspects and clinical importance. Clin Hemorheol Microcirc 2013; 53: 23-37.
38. Neumann FJ, Katus HA, Hoberg E, et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J 1991; 66: 425-430.
39. Baskurt OK, Bor-Kucukatay M, Yalcin O, et al. Standard aggregating media to test the "aggregability" of rat red blood cells. Clin Hemorheol Microcirc 2000; 22: 161-166.
40. Ajmani RS, Rifkind JM. Hemorheological Changes during Human Aging. Gerontology 1998; 44: 111-120.
41. Feher G, Koltai K, Kesmarky G, et al. Hemorheological parameters and aging. Clin Hemorheol Microcirc 2006; 35: 89-98.
42. Feher G, Koltai K, Toth K. Are hemorheological parameters independent of aging? Clin Hemorheol Microcirc 2007; 36: 181-182.
43. Manetta J, Aloulou I, Varlet-Marie E, et al. Partially opposite hemorheological effects of aging and training at middle age. Clin Hemorheol Microcirc 2006; 35: 239-244.
44. Desimone G, Devereux RB, Chien S, et al. Relation of blood-viscosity to demographic and physiologic variables and to cardiovascular risk-factors in apparently normal adults. Circulation 1990; 81: 107-117.
45. Carallo C, Irace C, De Franceschi MS, et al. The effect of aging on blood plasma viscosity. An 11.6 years follow-up study. Clin Hemorheol Microcirc 2011; 47: 67-74.
46. Galduroz JCF, Antunes HK, Santos RF. Gender- and age-related variations in blood viscosity in normal volunteers: A study of the effects of extract of Allium sativum and Ginkgo biloba. Phytomedicine 2007; 14: 447-451.
47. Cavestri R, Radice L, Ferrarini F, et al. Influence of erythrocyte aggregability and plasma fibrinogen concentration on CBF with aging. Acta Neurol Scand 1992; 85: 292-298.
48. Coppola L, Caserta F, De Lucia D, et al. Blood viscosity and aging. Arch Gerontol Geriatr 2000; 31: 35-42.
49. Hager K, Felicetti M, Seefried G. Fibrinogen and Aging. Aging (Milano) 1994; 6: 133-138.
50. Kovacs A, Szikszai Z, Varady E, et al. Study on the hemorheological parameters of oldest-old residents in the East-Hungarian city, Debrecen. Clin Hemorheol Microcirc 2006; 35: 83-88.
51. Laharragne PF, Cambus JP, Fillola G, et al. Plasma fibrinogen and physiological aging. Aging-Clin Exp Res 1993; 5: 445-449.
52. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of literature. Ann Intern Med 1993; 118: 956-963.
53. Avellone G, Garbo D, Panno AV, et al. Haemorheological components in the pre-geriatric and geriatric age range in a randomly selected western Sicily population sample (Casteldaccia Study). Clin Hemorheol 1993; 13: 83-92.
54. Christy RM, Baskurt OK, Gass GC, et al. Erythrocyte aggregation and neutrophil function in an aging population. Gerontology 2010; 56: 175-180.
55. Fu AZ, Nair SK. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol-Endocrinol Metabol 1998; 275: E1023-E1030.
56. Ward WF. The relentless effects of the aging process on protein turnover. Biogerontology 2000; 1: 195-199.
57. Toyama BH, Hetzer MW. Protein homeostasis: live long, won't prosper. Nature Rev Mol Cell Biol 2013; 14: 55-61.
58. Austin GE, Mullins RH, Morin LG. Non-Enzymic Glycation of Individual Plasma-Proteins in Normoglycemic and Hyperglycemic Patients. Clin Chem 1987; 33: 2220-2224.
59. Brownlee M, Vlassara H, Cerami A. Non-Enzymatic Glycosylation Reduces the Susceptibility of Fibrin to Degradation by Plasmin. Diabetes 1983; 32: 680-684.
60. Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proinflammatory state. Blood 2005; 105: 2294-2299.
61. Anuurad E, Enkhmaa B, Gungor Z, et al. Age as a Modulator of Inflammatory Cardiovascular Risk Factors. Arterioscler Thromb Vasc Biol 2011; 31: 2151-2156.
62. Yip R, Johnson C, Dallman PR. Age-Related-Changes in Laboratory Values Used in the Diagnosis of Anemia and Iron-Deficiency. Am J Clin Nutr 1984; 39: 427-436.
63. Ujie H, Kawasaki Y, Suzuki Y, et al. Influence of age and hematocrit on the coagulation of blood. Biorheology 2009; 23: 111-114.
64. Mayer GA. Diurnal, postural and postprandial variations of hematocrit. Can Med Assoc J 1965; 93: 1006-1008.
65. Glass GA, Gershon D, Gershon H. Some characteristics of the human-erythrocyte as a function of donor and cell age. Exp Hematol 1985; 13: 1122-1126.
66. Pinkofsky HB. The effect of donor age on human erythrocyte density distribution. Mech Age Dev 1997; 97: 73-79.
67. Yaari A. Mobility of human red blood cells of different age groups in an electric field. Blood 1969; 33: 159-163.
68. Eylar EH, Madoff MA, Brody OV, et al. The contribution of sialic acid to the surface charge of the erythrocyte. J Biol Chem 1961; 237: 1992-2000.
69. Huang YX, Wu ZJ, Mehrishi J, et al. Human red blood cell aging: correlative changes in surface charge and cell properties. J Cell Mol Med 2011; 15: 2634-2642.
70. Mazzanti L, Rabini RA, Salvolini E, et al. Sialic acid, diabetes, and aging: A study on the erythrocyte membrane. Met-Clin Exp 1997; 46: 59-61.
71. Ward KA, Baker C, Roebuck L, et al. Red-Blood-Cell Deformability - Effect of Age and Smoking. Age 1991; 14: 73-77.
72. Baskurt OK, Temiz A, Meiselman HJ. Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med 1998; 24: 102-110.
73. Hebbel RP, Leung A, Mohandas N. Oxidation-induced changes in microrheologic properties of the red blood cell membrane. Blood 1990; 76: 1015-1020.
74. Uyesaka N, Hasegawa S, Ishioka N, et al. Effect of superoxide anions on red cell deformability and membrane proteins. Biorheology 1992; 29: 217-229.
75. Baskurt OK. Activated granulocyte induced alterations in red blood cells and protection by antioxidant enzymes. Clin Hemorheol 1996; 16: 49-56.
76. Chasis JA, Mohandas N. Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations. J Cell Biol 1986; 103: 343-350.
77. Snyder LM, Fortier N, Trainor J, et al. Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking. J Clin Invest 1985; 76: 1971-1977.
78. Simmonds MJ, Meiselman HJ, Marshall-Gradisnik SM, et al. Assessment of oxidant susceptibility of red blood cells in various species based on cell deformability. Biorheology 2011; 48: 293-304.
79. Liochev SI. Reactive oxygen species and the free radical theory of aging. Free Rad Biol Med 2013; 60: 1-4.
80. Goi G, Cazzola R, Tringali C, et al. Erythrocyte membrane alterations during ageing affect beta-D-glucuronidase and neutral sialidase in elderly healthy subjects. Exp Gerontol 2005; 40: 219-225.
81. Amano M, Imataka K, Suzuki K, et al. Age-Related Reduction in the Number of Rabbit Erythrocyte Na, K-Atpase. Tohoku J Exp Med 1989; 159: 131-137.
82. Simat BM, Morley JE, From AH, et al. Variables affecting measurement of human red cell Na+,K+APTase activity: technical factors, feeding, aging. Am J Clin Nutr 1984; 40: 339-345.
83. Tsuda K, Nishio I, Masuyama Y. The role of sodium-potassium adenosine triphosphatase in the regulation of membrane fluidity of erythrocytes in spontaneously hypertensive rats: an electron paramagnetic resonance investigation. Am J Hypertens 1997; 10: 1411-1414.
84. Ajmani RS, Fleg JL, Demehin AA, et al. Oxidative stress and hemorheological changes induced by acute treadmill exercise. Clin Hemorheol Microcirc 2003; 28: 29-40.
85. Oostenbrug GS, Mensink RP, Hardeman MR, et al. Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E. J Appl Physiol 1997; 83: 746-752.
86. Yalcin O, Erman A, Muratli S, et al. Time course of hemorheological alterations after heavy anaerobic exercise in untrained human subjects. J Appl Physiol 2003; 94: 997-1002.
87. Novosadova J. The changes in hematocrit, hemoglobin, plasma volume and proteins during and after different types of exercise. Eur J Appl Physiol Occup Physiol 1977; 36: 223-230.
88. Ernst E. Influence of Regular Physical-Activity on Blood Rheology. Eur Heart J 1987; 8: 59-62.
89. Rosengren A, Wilhelmsen L, Welin L, et al. Social influences and cardiovascular risk-factors as determinants of plasma-fibrinogen concentration in a general-population sample of middle-aged men. Br Med J 1990; 300: 634-638.
90. Stratton JR, Chandler WL, Schwartz RS, et al. Effects of Physical Conditioning on Fibrinolytic Variables and Fibrinogen in Young and Old Healthy-Adults. Circulation 1991; 83: 1692-1697.
91. Gleeson M, Bishop NC, Stensel DJ, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nature Rev Immunol 2011; 11: 607-615.
92. Kilic-Toprak E, Ardic F, Erken G, et al. Hemorheological responses to progressive resistance exercise training in healthy young males. Med Sci Mon 2012; 18: CR351-CR360.
93. Aloulou I, Varlet-Marie E, Mercier J, et al. Hemorheologic effects of low intensity endurance training in sedentary patients suffering from the metabolic syndrome. Clin Hemorheol Microcirc 2006; 35: 333-339.
94. Simmonds MJ, Minahan CL, Serre KR, et al. Preliminary findings in the heart rate variability and haemorheology response to varied frequency and duration of walking in women 65-74 yr with type 2 diabetes. Clin Hemorheol Microcirc 2012; 51: 87-99.
95. Smith JA, Martin DT, Telford RD, et al. Greater erythrocyte deformability in world-class endurance athletes. Am J Physiol-Heart Circ Physiol 1999; 276: H2188-H2193.
96. Connes P, Simmonds MJ, Brun JF, et al. Exercise hemorheology: Classical data, recent findings and unresolved issues. Clin Hemorheol Microcirc 2013; 53: 187-199.